J. Schleicher

发表

Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor.

W. Siegert, O. Rick, J. Beyer, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.

C. Bokemeyer, L. Kanz, U. Vanhoefer, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic Renal Cell Carcinoma (mRCC). Is There A Role of F-18-FDG-PET?

F. Eisenberger, K. Willms, H. Bihl, 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

N. Schmitz, M. Stauch, Y. Ko, 2020, Leukemia.

EFFECTIVE THERAPEUTIC MEASURES FOR REDUCING LIPOPROTEIN (A) IN PATIENTS WITH DYSLIPIDEMIA. LIPOPROTEIN (A) REDUCTION WITH SUSTAINED-RELEASE BEZAFIBRAT E

J. Schleicher, W. Schwartzkopff, H. Baeyer, 1991 .

Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

J. Panse, M. Vehreschild, D. Buchheidt, 2020, Mycoses.

Detection of small numbers of immature cells in the blood of healthy subjects.

D. Huhn, B. Oertel, J. Schleicher, 1998, Journal of clinical pathology.

Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy

D. Huhn, W. Siegert, J. Beyer, 1997, Cancer.

Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer

C. Bokemeyer, L. Kanz, M. Kuczyk, 2005, Journal of Cancer Research and Clinical Oncology.

Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

R. Greil, K. Döhner, R. Schlenk, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PBPC mobilization with paclitaxel, ifosfamide, and G‐CSF with or without amifostine: results of a prospective randomized trial

W. Siegert, O. Rick, J. Beyer, 2001, Transfusion.

THE EFFECT OF FK506 VERSUS CYCLOSPORINE ON GLUCOSE AND LIPID METABOLISM—A RANDOMIZED TRIAL

W. Bechstein, P. Neuhaus, K. Leder, 1994, Transplantation.

Impact of gemtuzumab ozogamicin on MRD and relapse risk in NPM1 mutated AML patients: results from the AMLSG 09-09 Trial.

L. Bullinger, K. Döhner, R. Schlenk, 2020, Blood.

Minimal Residual Disease Monitoring in Acute Myeloid Leukemia (AML) with Translocation t(8;21)(q22;q22): Results of the AML Study Group (AMLSG)

R. Greil, L. Bullinger, K. Döhner, 2016 .

Central venous catheter-related infections in hematology and oncology

H. Einsele, P. Staber, G. Fätkenheuer, 2008, Annals of Hematology.

Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.

C. Bokemeyer, L. Kanz, L. Looijenga, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunotyping of blasts in human bone marrow

D. Huhn, B. Oertel, J. Schleicher, 1996, Annals of Hematology.

Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation

D. Huhn, W. Siegert, R. Blasczyk, 1998, Bone Marrow Transplantation.

High-dose chemotherapy in germ cell tumours: a large single centre experience.

D. Huhn, W. Siegert, O. Rick, 1998, European journal of cancer.

Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

J Schleicher, C. Bokemeyer, L. Kanz, 2002, British Journal of Cancer.

Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1-Mutated Acute Myeloid Leukemia

R. Greil, L. Bullinger, K. Döhner, 2022, Blood.

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.

J Schleicher, C. Bokemeyer, L. Kanz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.

L. Bullinger, K. Döhner, R. Schlenk, 2020, Blood.

Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.

C. Bokemeyer, T. Gauler, M. Kuczyk, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.

C. Bokemeyer, R. Schirren, W. Berdel, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of Postchemotherapy Surgery in the Management of Patients With Liver Metastases From Germ Cell Tumors

C. Bokemeyer, L. Kanz, T. Gauler, 2005, Annals of surgery.

Mobilization of peripheral blood progenitor cells by disease-specific chemotherapy in patients with soft tissue sarcoma

D. Huhn, H. Riess, O. Rick, 1998, Bone Marrow Transplantation.

Bendamustine hydrochloride in patients with refractory soft tissue sarcoma

L. Kanz, J. Huober, V. Grünwald, 2007, Cancer.

Acquired haemophilia mimicking dermatitis artefacta.

C. Garbe, M. Röcken, C. Brod, 2008, Acta dermato-venereologica.

Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction.

C. Han, J. Schleicher, W. Schwartzkopff, 1990, Atherosclerosis.

Clinical Relevance of Minimal Residual Disease Monitoring in NPM1 Mutated AML: A Study of the AML Study Group (AMLSG)

K. Döhner, R. Schlenk, H. Döhner, 2015 .

Sequential treatment with pazopanib followed by nivolumab in patients with renal cell carcinoma: Updated interim results of the non-interventional study PAZOREAL.

V. Grünwald, J. Bedke, P. Goebell, 2020 .

Sequential treatment with pazopanib (PAZO) followed by nivolumab (NIVO) in patients with advanced or metastatic renal cell carcinoma (mRCC): Third interim results of the non-interventional study PAZOREAL.

V. Grünwald, J. Bedke, P. Goebell, 2019, Journal of Clinical Oncology.

Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL.

J. Bedke, P. Goebell, T. Steiner, 2018 .

Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

H. Einsele, H. Wolf, X. Schiel, 2006, Annals of Hematology.

Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.

R. Greil, L. Bullinger, K. Döhner, 2023, The Lancet. Haematology.

Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy

D. Huhn, W. Siegert, J. Beyer, 1997, Cancer.